论文投稿时一般要求附带一篇“Cover Letter”，好的“Cover Letter”不仅可以使文章锦上添花，更有可能直接决定论文是否被录用。本人切身体会，以已发表论文为例，现将其写法经验归纳如下：
Dear Editor,
We would like to submit the enclosed manuscript entitled "论文题目", which we wish to be considered for publication in 期刊名.
The work described has not been submitted elsewhere for publication, in whole or in part, and all the authors listed have approved the manuscript that is enclosed.We believe that two aspects of this manuscript will make it interesting to general readers of yourjournal.
First, 论文亮点1.
Second, 论文亮点2.
Thank you very much for your time and consideration.
Sincerely yours,
作者名
注意点：论文亮点一定要简洁明了，一定要有创新，突出你的文章与其它已发表论文的区别。这是 Cover Letter 的主要内容。
1、 什么是cover letter?
指的是SCI论文投稿信
2、cover letter的内容主要包括那些?
应该简述所投稿件的核心内容、主要发现和意义,拟投期刊,对稿件处理有无特殊要求等(如“not to review”list)。另外,请附上主要作者的中文姓名、通讯地址、电话、传真和e-mail地址。此外有的杂志要求推荐几位审稿人及其。以及谁已经阅读过该文(当然是牛人)。SCI论文发表投稿信写作相关知识，请咨询“辑文编译”。
我投的那个杂志是要求说明你论文研究的意义,以及与这个杂志的相关性,另外还有的可能要
写明你没有一搞多投等。此外临床实验要求写明符合伦理学要求。
3、 如何写SCI论文cover letter?
各个杂志的具体要求是不一样的,在杂志的guide for authors一般会有要求。如果没有具体的要求,大家可按照通用要求处理。SCI论文发表投稿信写作相关知识，请咨询“辑文编译”。
4、SCI论文投稿信常用模板:
(1)Dear Mr. **
1. The work described has not been submitted elsewhere forpublication, in whole or in part, and all the authors listed have approved themanuscript that is enclosed.
2. I have read and have abided by the statement of ethicalstandards for manuscripts submitted to Neuroscience.kind regards.
Your sincerely,
通讯作者
(2)Dear Dr. 主编name:
We submit our manuscript entitled " 文章title" to 杂志名for publication.
接着简单介绍你文章的主要创新点和意义,不易过多,但要突出新意和关键点。
All authors have seen the manuscript and approved to submitto your journal.
Thank you very much for your attention and consideration.
Sincerely yours,
通讯作者
(3)Dear Dr. 主编name:
We submit our manuscript entitled " 文章title" to 杂志名for publication.
接着简单介绍你文章的主要创新点和意义,不易过多,但要突出新意和关键点。
All authors have seen the manuscript and approved to submitto your journal.
Thank you very much for your attention and consideration.
Sincerely yours,
通讯作者
(4)Dr. ***
Editor-in-Chief, ***
(add address) January 22, 2003
Dear Dr. **,
Enclosed herewith please find 3 copies of a MS by: ‘***. ***and ***'
entitled: “**********”, which we would like to submit for publicationin the ‘******'.
Looking forward to your decision,
With kind personal regards,
Sincerely yours,
*****
Professor of ***
(5)Dear Prof. ***:
This is a manuscript by**and **entitled “……”。 It is submitted to be considered for publication as a “…” in your journal. This paper is new.
Neither the entire paper nor any part of its content has been published or has been accepted elsewhere. It is not being submitted to any other journal.
We believe the paper may be of particular interest to the readers of your journal as it ……
Correspondence should be addressed to **at the following address, phone and fax number, and email address:…
Thanks very much for your attention to our paper.
Sincerely yours,
editorial文章CI论文投稿cover letter 投稿信模版
Dear editorial board of European Journal of Cardiology,
Please find enclosed the manuscript: “The angiotensin-converting enzyme is not a risk factor for myocardial infarction in French individuals”, by Sarah H., et al., to be submitted as a Short Communication to the European Journal of Neurology for consideration of publication. All co-authors have seen and agree with the contents of the manuscript and there is no financial interest to report. We certify that the submission is original work and is not under review at any other publication.
In this manuscript, we report the results of the first study on the genetic and functional roles of the ACE on the risk of suffering a myocardial infarction in the French population. Indeed, we genotyped the rs4341 polymorphism in 531 IS cases and 549 healthy controls, and then performed functional studies by measuring serum ACE protein level and activity in hea
lthy controls, stroke patients at baseline and stroke patients 24h after stroke symptoms onset. The results from our study did not reveal any association of the ACE variant with myocardial infarction, although it affected ACE protein level, and ischemic stroke patients showed lower ACE level than controls in the acute phase but not in the chronic phase.
We believe that our findings could be of interest to the readers of European Journal of Cardiology because they bring new and strong evidence that the ACE gene and protein are not a risk factor for myocardial infarction.